Ignite Creation Date:
2024-05-06 @ 7:46 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06133088
Status:
RECRUITING
Last Update Posted:
2023-11-15
First Post:
2023-10-31
Brief Title:
Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK46 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer a Phase 2 Clinical Trial
Sponsor:
Organization:
Zhejiang Cancer Hospital